17 alpha-hydroxylase deficiency overview: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Congenital adrenal hyperplasia due to | {{Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
==Historical Perspective== | |||
{{ | ==Classification== | ||
==Pathophysiology== | |||
==Causes== | |||
==Differential Diagnosis== | |||
==Epidemiology and Demographics== | |||
==Risk Factors== | |||
==Screening== | |||
==Natural history, Complications and Prognosis== | |||
==History and Symptoms== | |||
==Physical Examination== | |||
==Laboratory Findings== | |||
==CT== | |||
==MRI== | |||
==Echocardiography or Ultrasound== | |||
==Other Imaging Findings== | |||
==Other Diagnostic Studies== | |||
==Medical Therapy== | |||
==Surgery== | |||
==Prevention== | |||
==Reference== | |||
{{Reflist}} | |||
[[Category:Disease]] | |||
[[Category:Pediatrics]] | |||
[[Category:Endocrinology]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Intersexuality]] | |||
Revision as of 19:59, 4 February 2016
|
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency overview On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency overview |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]